| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |